Chronic Graft-Versus-Host Disease

Establishment of Biomarker Panel For Forecasting Chronic Graft-Versus-Host Disease (cGVHD) After Allo-HSCT

Alvelestat (MPH966), an Oral Neutrophil Elastase Inhibitor, in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation

Digital Health Intervention to Promote Quality of Life in Adults With Chronic Graft Versus Host Disease

Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease

Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease

Psychosocial Mobile App for Chronic Graft-Versus-Host Disease

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease

Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

A Prospective Observational Study for Evaluating CGVHD

Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide

MSC for Treatment of cGVHD After Allo-HSCT

Imatinib Mesylate and Mycophenolate Mofetil for Steroid-Refractory Sclerotic/Fibrotic cGVHD in Children

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus

Safety and Efficacy Study of R932348 Ophthalmic Solution in Chronic Ocular Graft Versus Host Disease Patients(DROPS-2)

Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)

Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)